Screener
OrthoPediatrics KIDS Sales & Marketing
Sales & Marketing at other companies
Other financials
Where this comes from
Reported directly by OrthoPediatrics in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The source filing: OrthoPediatrics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 1:56 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001425450-26-000070
FAQ
- What is OrthoPediatrics's sales & marketing?
- OrthoPediatrics (KIDS) reported sales & marketing of $21.29M in Q2 2026.
- How has OrthoPediatrics's sales & marketing changed year-over-year?
- OrthoPediatrics's sales & marketing increased by 11.5% year-over-year, from $19.1M to $21.29M.
- What is the long-term trend for OrthoPediatrics's sales & marketing?
- Over 4 years (2021 to 2025), OrthoPediatrics's sales & marketing has grown at a 16.4% compound annual growth rate (CAGR), from $39.67M to $72.73M.
- What does sales & marketing mean?
- Selling And Marketing Expense as reported by OrthoPediatrics Corp. Common Stock.
Ask your AI about OrthoPediatrics's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude